Gainers
- Atossa Genetics Inc ATOS shares jumped 242.4 percent to $5.17 after the company received FDA approval of oral Endoxifen for 'expanded access' as a post-mastectomy treatment for a US breast cancer patient.
- Hancock Jaffe Laboratories, Inc. HJLI shares jumped 63.8 percent to $2.85 after surging 19.18 percent on Wednesday.
- WageWorks, Inc. WAGE shares gained 34.3 percent to $40.12 after the company said it expects to file the majority of its delayed quarterly and annual reports before evening on March 19. As a result, it expects its common stock to remain listed on the NYSE.
- MongoDB, Inc. MDB rose 27.4 percent to $132.78 after the company reported better-than-expected Q4 EPS and sales results. The company also issued Q1 EPS and sales guidance above analyst estimates.
- Akari Therapeutics, Plc AKTX rose 25.7 percent to $7.42 after surging 224.18 percent on Wednesday. The company announced a successful Type B, pre-IND meeting with the FDA regarding Akari's proposed pivotal clinical trial program for hematopoietic stem cell transplant-related thrombotic microangiopathy.
- Domo, Inc. DOMO shares rose 23.4 percent to $38.50 after the company reported better-than-expected Q4 EPS and sales results. The company also issued Q1 EPS and sales guidance above analyst estimates.
- Neos Therapeutics, Inc. NEOS climbed 23.4 percent to $2.74 after the company reported better-than-expected Q4 EPS and sales.
- Smith Micro Software, Inc. SMSI gained 22.6 percent to $2.28 after the company reported higher-than-expected Q4 EPS and sales results.
- Evoke Pharma, Inc. EVOK rose 21.7 percent to $1.46 after the FDA granted the company its requested pre-PDUFA date meeting to be held on March 21, 2019.
- Safe-T Group Ltd SFET climbed 21.3 percent to $2.73 after gaining 5.63 percent on Wednesday.
- KalVista Pharmaceuticals, Inc. KALV gained 18.6 percent to $31.12 after reporting narrower-than-expected Q3 loss.
- Boxlight Corporation BOXL climbed 15.6 percent to $2.9696 after the company completed its acquisition of Modern Robotics, Inc.
- Farmland Partners Inc. FPI rose 14.3 percent to $6.15 following Q4 results.
- Talos Energy Inc. TALO surged 13.9 percent to $25.90 following strong Q4 results.
- AstroNova, Inc. ALOT gained 12.3 percent to $19.50 after reporting Q4 results.
- The ExOne Company XONE jumped 12.3 percent to $10.58 following upbeat Q4 earnings.
- Avalon GloboCare Corp. AVCO climbed 12.2 percent to $4.6311.
- Sophiris Bio Inc SPHS rose 11.6 percent to $1.0600 after the company reported higher-than-expected Q4 EPS results.
- RadNet, Inc. RDNT gained 11.4 percent to $15.49 following strong Q4 results.
- Smart Sand, Inc. SND shares rose 11.1 percent to $3.30 after reporting upbeat Q4 results.
- Snap Inc. SNAP climbed 10.2 percent to $11.07 after BTIG Research upgraded the company's stock from Neutral to Buy with a $15 price target. Jefferies also raised its price target on the company's stock from $9 per share to $11 per share.
- Fluidigm Corporation FLDM climbed 9 percent to $13.94. BTIG Research initiated coverage on Fluidigm with a Buy rating and a $15 price target.
- Forum Energy Technologies, Inc. FET gained 8.5 percent to $6.13.
- National General Holdings Corp. NGHC climbed 8.2 percent to $25.89.
- Melinta Therapeutics, Inc. MLNT shares rose 8.1 percent to $5.22 after the company reported higher-than-expected Q4 EPS and sales results.
- Midstates Petroleum Company, Inc. MPO rose 6.7 percent to $8.66 following Q4 results.
Check out these big penny stock gainers and losers
Losers
- Legacy Reserves Inc LGCY shares dipped 47.5 percent to $0.7300 after the company announced a review of strategic alternatives. Alternatives include a sale or other business combination transaction, sales of assets and financing transactions.
- Union Acquisition Corp. LTN shares declined 31.6 percent to $6.45. Union Acquisition reported updated timing for completion of initial business combination with Bioceres LLC.
- Tailored Brands, Inc. TLRD dropped 24.7 percent to $8.80 after the company reported lower-than-expected Q4 sales results.
- FTD Companies, Inc. FTD declined 23 percent to $1.2550 after the company reported Q4 sales of $247.5 million, down from $278.1 million last year, and cut FY19 sales and EBITDA guidance.
- Fusion Connect, Inc. FSNN dipped 21.9 percent to $1.39 after the company postponed its fourth quarter and full year 2018 financial results conference call in order to complete its 2018 audit.
- Uxin Limited UXIN fell 16.1 percent to $3.8600 after the company reported Q4 results.
- Smart & Final Stores Inc SFS fell 15.9 percent to $5.30 after the company reported weaker-than-expected earnings for its fourth quarter.
- Seelos Therapeutics, Inc. SEEL shares dropped 14.9 percent to $2.8084 after falling 14.29 percent on Wednesday
- Cloudera, Inc. CLDR fell 14.8 percent to $12.45 after the company reported lower-than-expected Q4 EPS. The company also issued Q1 EPS guidance below analyst estimates.
- AquaBounty Technologies, Inc. AQB dropped 14.6 percent to $3.1099.
- Axovant Sciences Ltd AXGT fell 14 percent to $1.5050. Axovant Sciences priced its 26.67 million share common stock offering at $1.50 per share.
- Huami Corporation HMI dropped 13.8 percent to $14.45 after reporting Q4 results.
- NN, Inc. NNBR shares fell 13.2 percent to $7.86 after the company reported lower-than-expected Q4 EPS and sales. The company said it faced market headwinds, customer issues in its Power Solutions segment and a slowing market in the Mobile Solutions segment.
- Build-A-Bear Workshop, Inc. BBW fell 12.3 percent to $5.17.
- Aquestive Therapeutics, Inc. AQST dropped 12.1 percent to $6.60 following Q4 results.
- Tenneco Inc. TEN shares fell 11.5 percent to $29.39 following downbeat quarterly earnings.
- Ocean Power Technologies, Inc. OPTT shares dropped 11 percent to $4.7913.
- Avalon Holdings Corporation AWX shares declined 10.7 percent to $2.9024.
- eGain Corporation EGAN fell 10.5 percent to $11.15 after the company priced a 2 million share common stock offering at $11 per share.
- Iconix Brand Group, Inc. ICON shares dropped 10.2 percent to $2.55.
- Dollar General Corporation DG fell 9.1 percent to $109.80 after the company reported weaker-than-expected earnings for its fourth quarter and issued weak 2019 outlook. The company raised its quarterly dividend from $0.29 to $0.32 per share and reported a $1 billion buyback plan.
- Global Medical REIT Inc. GMRE shares fell 8.5 percent to $9.85. Global Medical REIT priced its 7.25 million share offering at $9.75 per share.
- Globus Maritime Limited GLBS shares dipped 8.4 percent to $5.43.
- TrovaGene, Inc. TROV dropped 8 percent to $3.95.
- INSYS Therapeutics, Inc. INSY fell 7.8 percent to $3.9200 after dropping 25.18 percent on Wednesday.
- Semtech Corporation SMTC fell 7.5 percent to $51.36 after the company issued Q1 EPS and sales guidance below analyst estimates.
- Hexindai Inc. HX dropped 7.3 percent to $2.81.
- Genesco Inc. GCO fell 5.2 percent to $44.12 after the company reported downbeat earnings for its fourth quarter and issued weak FY20 earnings forecast.
- Galmed Pharmaceuticals Ltd. GLMD fell 5.1 percent to $8.01. On Wednesday, Galmed Pharmaceuticals reported downbeat Q4 earnings.
- Second Sight Medical Products Inc EYES fell 5 percent to $0.8001 after the company reported lower-than-expected Q4 sales results.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsMovers & ShakersIntraday UpdateMarketsMoversTrading IdeasGeneralEnergyInformation TechnologyIT Consulting & Other ServicesLosersOil & Gas Exploration & ProductionTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in